Evidence map›Paper›PMID 38375508›Full record

ArticleFrontiers in molecular biosciences2024

Nuha T Swaidan, Nada H Soliman, Ahmed T Aboughalia, Toqa Darwish, Ruba O Almeshal, Azhar A Al-Khulaifi, Rowaida Z Taha, Rania Alanany, Ahmed Y Hussein, Salam Salloum-Asfar and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nuha T SwaidanBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Nada H SolimanBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Ahmed T AboughaliaBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Toqa DarwishBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Ruba O AlmeshalBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Azhar A Al-KhulaifiBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Rowaida Z TahaNeurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Rania AlananyCollege of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
Ahmed Y HusseinSchool of Medicine, New Giza University, Giza, Egypt.
Salam Salloum-AsfarNeurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Sara A AbdullaNeurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Abdallah M AbdallahBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
Mohamed M EmaraBasic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reprogramming human somatic cells into a pluripotent state, achieved through the activation of well-defined transcriptional factors known as OSKM factors, offers significant potential for regenerative medicine. While OSKM factors are a robust reprogramming method, efficiency remains a challenge, with only a fraction of cells undergoing successful reprogramming. To address this, we explored genes related to genomic integrity and cellular survival, focusing on iPSCs (A53T-PD1) that displayed enhanced colony stability. Our investigation had revealed three candidate genes

Indexed as

cellular survivalESCsgenomic integrityiPSCstranscription factors

Identifiers

PMID38375508
PMCPMC10875024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.